GlassScriptPhysician profile
Jane M Parks
NPI 1164418661
$2,524.69
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $675 · 2020: $469 · 2021: $580 · 2022: $583 · 2023: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $505.89 | 2019-2023 | Nucala, Trelegy Ellipta |
| Insmed, INC. | $409.32 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $254.64 | 2019-2023 | Breztri, Andexxa, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.17 | 2019-2022 | |
| Grifols USA, LLC | $184.09 | 2019-2022 | |
| Harmony Biosciences LLC | $149.26 | 2020-2022 | |
| Jazz Pharmaceuticals INC. | $83.83 | 2021-2022 | |
| Mylan Specialty L.P. | $83.79 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $73.36 | 2019 | |
| Advanced Respiratory, INC | $69.73 | 2020-2021 | |
| Genentech USA, INC. | $68.21 | 2019-2021 | |
| Philips North America LLC | $57.86 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $55.85 | 2021 | |
| Livanova USA, INC. | $39.03 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $28.35 | 2021-2023 | Cinqair |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $27.72 | 2022 | |
| Inspire Medical Systems, INC. | $25.30 | 2023 | Inspire |
| Ethicon INC. | $24.62 | 2019 | |
| Axsome Therapeutics, INC. | $23.76 | 2022 | |
| Genzyme Corporation | $21.08 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.57 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $18.13 | 2022 | |
| Abbvie INC. | $15.80 | 2023 | |
| Merck Sharp & Dohme LLC | $14.68 | 2019 | |
| Ambu INC. | $14.36 | 2021 | |
| Electromed, INC. | $12.18 | 2021 | |
| Inogen, INC. | $12.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Parks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.